Filter
3847
Filtered Results: 3847
Text search:
early
disease
detection
Featured
Recommendations
404
New Publications
1035
Language
Document type
No document type
2152
Studies & Reports
617
Guidelines
559
Strategic & Response Plan
174
Manuals
165
Fact sheets
77
Situation Updates
38
Training Material
37
Infographics
9
Brochures
6
Resource Platforms
6
Online Courses
3
Videos
3
App
1
Countries / Regions
India
249
Global
169
Western and Central Europe
110
Kenya
90
Sierra Leone
82
Ethiopia
78
Nigeria
70
South Africa
69
Liberia
68
Bangladesh
65
Latin America and the Carribbean
65
Uganda
63
Africa
61
Tanzania
54
Rwanda
54
Nepal
53
Malawi
52
Myanmar / Burma
48
Syria
47
South–East Asia Region
39
Zambia
38
Eastern Europe
38
Congo, Democratic Republic of
37
Ghana
36
Philippines
32
Ukraine
32
Guinea
29
South Sudan
28
East and Southern Africa
28
Asia
28
Cambodia
27
Russia
26
West and Central Africa
25
Zimbabwe
24
Mozambique
23
Namibia
21
Germany
20
Middle East and North Africa
20
Indonesia
19
Yemen
18
Senegal
17
Pakistan
17
Brazil
17
Eastern Europe and Central Asia
17
Haiti
15
Lesotho
14
Botswana
13
Western Pacific Region
13
USA
12
Madagascar
12
Somalia
11
Colombia
11
Afghanistan
10
Sudan
10
North America
10
Cameroon
9
Burkina Faso
8
Eswatini/ Swaziland
8
Venezuela
8
Vietnam
8
Thailand
7
Central African Republic
7
Peru
7
Angola
7
Iraq
6
Sri Lanka
6
Georgia
6
Turkey
5
Chad
5
Papua New Guinea
5
Burundi
5
Ecuador
5
Chile
5
Albania
5
Tajikistan
5
Moldova
5
Bolivia
4
Greece
4
Laos
4
Mali
3
Niger
3
Togo
3
Lebanon
3
Gambia
3
Benin
3
North Macedonia
3
Libya
3
Southern Africa
3
Romania
3
Iran
3
United Kingdom
3
Portugal
3
Côte d’Ivoire / Ivory Coast
2
Saudi Arabia
2
Jordan
2
China
2
Mexico
2
Paraguay
2
Poland
2
Palestine
2
Timor Leste/ East Timor
2
Jamaica
2
France
2
Spain
2
Guinea-Bissau
1
Morocco
1
Egypt
1
Malaysia
1
Mauritania
1
Ireland
1
Argentina
1
Dominican Republic
1
Serbia
1
Hungary
1
Honduras
1
El Salvador
1
Cape Verde
1
Other region
1
Bhutan
1
Italy
1
Djibouti
1
Canada
1
Bulgaria
1
Estonia
1
Slovakia
1
Uzbekistan
1
Kyrgyzstan
1
Australia
1
Uruguay
1
Japan
1
Denmark
1
Belgium
1
Maldives
1
Mauritius
1
Tunisia
1
Belarus
1
Israel
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
1430
Clinical Guidelines
401
Public Health
235
Women & Child Health
158
Key Resources
111
Pharmacy & Technologies
55
Capacity Building
53
Annual Report MEDBOX
1
Toolboxes
COVID-19
415
TB
367
HIV
270
Mental Health
231
Rapid Response
204
NTDs
150
Ebola
131
AMR
104
NCDs
97
Conflict
88
Disability
86
Planetary Health
79
Refugee
69
Caregiver
61
Zika
51
Cholera
41
Pharmacy
34
Natural Hazards
33
Polio
31
Global Health Education
29
Specific Hazards
25
Health Financing Toolbox
18
Typhoon
2
South Sudan
1
In 2005, the World Health Organization (WHO) recognized Chagas disease (CD; Trypanosoma cruzi infection) as a neglected tropical disease (NTD) [1] and included it into the global plan to combat NTDs...
About six to seven million people worldwide, mostly in Latin America, are estimated to be infected with
Trypanosoma cruzi, the parasite that causes Chagas disease (WHO data from 2021). Chagas disease...
Epidemiology
Chagas disease (American trypanosomiasis) is caused by the protozoan parasite Trypanosoma cruzi, and transmitted to humans by infected triatomine bugs, and less commonly by transfusion, organ transplant, from mother to infant, and in r...
Chagas disease is currently endemic and also predicted to be at increased transmission risk under future climate change scenarios. Similarly, an expansion of areas in the United States at increased risk for Chagas ... transmission is also expected over the next several decades under climate change scenarios. Of particular interest is the predicted northern shift of triatomine species to central regions of the United States with historically unsuitable climates for T. cruzi vectors. The weight of evidence regarding the influences climate change may pose on T. cruzi vector species distributions demonstrates the sensitivity of Chagas disease transmission to future climate variability. In order to advance forecasts for the impact climate change may have on Chagas disease transmission in the Americas, it is imperative to
further develop, utilize, and perhaps combine predictive species distribution modeling approaches that integrate accurate, long term data on climate variables, vector species distributions, Chagas disease incidence, as well as other socio-ecological variables.
Ebola disease and Marburg disease outbreaks continue to occur in Africa, with increased frequency. In addition to resulting in high mortality and morbidity, the outbreaks generate fear and mistrust ...
The Infection prevention and control in the context of coronavirus disease 2019 (COVID-19): a living guideline consolidates technical guidance developed and published during the COVID-19 pandemic into evidence-informed recommendations for infection ...
Significant progress has been made in the eradication of three priority diseases in the African Region, as a result of extensive collaboration between the Regional Office, WHO country offices and countries. For example, in August 2020, the region wa...
Background: Cardiovascular disease (CVD), mainly heart attack and stroke, is the
leading cause of premature mortality in low and middle income countries (LMICs).
Identifying and managing individuals at high risk of CVD is an important strategy to ...
Atherosclerotic lower-extremity peripheral artery disease (PAD) is increasingly recognized as an important cause of cardiovascular morbidity and mortality that affects more than 230 million people worldwide. Traditional cardiovascular risk factors, ...
In 2015, the United Nations set important targets to reduce premature
cardiovascular disease (CVD) deaths by 33% by 2030. Africa disproportionately
bears the brunt of CVD burden and has one of the highest risks of dying
from non-communicable ... (NCDs) worldwide. There is currently
an epidemiological transition on the continent, where NCDs is projected
to outpace communicable diseases within the current decade. Unchecked
increases in CVD risk factors have contributed to the growing burden of three
major CVDs—hypertension, cardiomyopathies, and atherosclerotic diseasesleading to devastating rates of stroke and heart failure. The highest age
standardized disability-adjusted life years (DALYs) due to hypertensive heart
disease (HHD) were recorded in Africa. The contributory causes of heart failure
are changing—whilst HHD and cardiomyopathies still dominate, ischemic
heart disease is rapidly becoming a significant contributor, whilst rheumatic
heart disease (RHD) has shown a gradual decline. In a continent where health
systems are traditionally geared toward addressing communicable diseases,
several gaps exist to adequately meet the growing demand imposed by CVDs.
Among these, high-quality research to inform interventions, underfunded
health systems with high out-of-pocket costs, limited accessibility and
affordability of essential medicines, CVD preventive services, and skill
shortages. Overall, the African continent progress toward a third reduction
in premature mortality come 2030 is lagging behind. More can be done in
the arena of effective policy implementation for risk factor reduction and
CVD prevention, increasing health financing and focusing on strengthening
primary health care services for prevention and treatment of CVDs, whilst
ensuring availability and affordability of quality medicines. Further, investing
in systematic country data collection and research outputs will improve the accuracy of the burden of disease data and inform policy adoption on
interventions. This review summarizes the current CVD burden, important
gaps in cardiovascular medicine in Africa, and further highlights priority
areas where efforts could be intensified in the next decade with potential
to improve the current rate of progress toward achieving a 33% reduction
in CVD mortality.
Socioeconomic status is associated with differences in risk factors for cardiovascular disease incidence and outcomes, including mortality. However, it is unclear whether the associations between cardiovascular ... and common measures of socioeconomic status—wealth and education—differ among high-income, middle-income, and low-income countries, and, if so, why these differences exist. We explored the association between education and household wealth and cardiovascular disease and mortality to assess which marker is the stronger predictor of outcomes, and examined whether any differences in cardiovascular disease by socioeconomic status parallel differences in risk factor levels or differences in management.
The incidence and mortality of cardiovascular diseases (CVDs) in low and middle income countries (LMICs) have been increasing, while access to CVDs medicines is suboptimal. We assessed selection of essential medicines for the prevention and treatmen...
Non-communicable diseases (NCDs) are of increasing concern for society and national governments, as well as globally due to their high mortality rate. The main risk factors of NCDs can be classified into the categories of self-management, genetic fa...
In this document, the Inter-American Committee of Cardiovascular Prevention and Rehabilitation, together with the South
American Society of Cardiology, aimed to formulate strategies, measures, and actions for cardiovascular disease prevention
and ...
This global status report on prevention and control of NCDs (2014), is framed around the nine voluntary global targets. The report provides data on the current situation, identifying bottlenecks as well as opportunities and priority actions for attaining the targets. The 2010 baseline estimates on N...
Noncommunicable diseases (NCDs) – chief among them, cardiovascular diseases (heart disease and stroke), cancer, diabetes and chronic respiratory ...
Noncommunicable diseases (NCDs) – chief among them, cardiovascular diseases (heart disease and stroke), cancer, diabetes and chronic respiratory ...
The "WHO Package of Essential Noncommunicable (PEN) Disease Interventions for Primary Health Care" provides a set of cost-effective, evidence-based interventions to address noncommunicable diseases ...
This threat assessment addresses the implications of the ongoing Marburg virus disease (MVD) outbreak in
Rwanda for the European Union/European Economic Area (EU/EEA). MVD is a severe disease in hu...
The guide aims to provide health and DRM practitioners, planners and policymakers across sectors with targeted information to help them strengthen national health systems and integrate the risks of disease outbreaks in national DRR strategies
The...
